CoChat

High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia

Open access

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index; none of the 32 sources its claims cite is checked for support yet.

Abstract

The rise of antimalarial drug-resistant Plasmodium falciparum threatens malaria elimination efforts. Mutations in the gene kelch13 ( k13 ) confer artemisinin partial resistance (ART-R), compromising the efficacy of frontline artemisinin-based combination therapies (ACTs). The validated mutation k13 R622I has emerged and expanded rapidly in the Horn of Africa. We conducted a year-long genomic surveillance study in Gondar Zuria and Tach Armachiho, two ecologically distinct districts in northwestern Ethiopia where R622I was first identified. A total of 903 P. falciparum infections were sequenced using molecular inversion probe (MIP) panels targeting major drug resistance mutations and genome-wide informative SNPs. The R622I mutation was found in 44.3% of samples, more frequent in Gondar Zuria than Tach Armachiho (52% vs. 35%; p < 0.001 ), and persisted year-round in nearly all sites, indicating stable transmission with minimal seasonal variation. Histidine-rich protein 2 (HRP2) based rapid diagnostic test (RDT) negativity was also prevalent (39.3%), with significant district-level variation (48.7% vs. 27.6%; p < 0.001 ). Concerningly, R622I and HRP2-RDT co-occured in 22% of samples, higher in Gondar Zuria than in Tach Armachiho (28.9% vs. 12.9%; p < 0.00 1). Overall, HRP2-RDT negativity was significantly more common among R622I mutant parasites than wild-type (48.3% vs. 30.7%; p < 0.05). The k13 C580Y mutation was also detected at very low frequency (0.4%) in Gondar Zuria, representing the first report of this mutation in the Horn of Africa. Long-read whole-genome sequencing showed k13 flanking haplotypes of C580Y isolates were distinct from Southeast Asian lineages, suggesting a local, de novo emergence of African origin. These findings highlight the increasing prevalence and types of ART-R mutations, persistence of k13 R622I and its increasing association with HRP2-RDT negativity, representing a double threat to malaria control and elimination efforts.

Overview

CoChat Summary

TL;DR

In a year-long genomic surveillance study in two districts of northwestern Ethiopia, k13 R622I was found in 44.3% of successfully typed P. falciparum infections and HRP2-based RDT negativity in 39.3%, with co-occurrence in 22.0%. R622I was more common in Gondar Zuria than Tach Armachiho, persisted year-round, and was associated with higher RDT negativity; two C580Y cases were also detected and appeared locally emergent.

Key findings

  • k13 R622I was detected in 369/833 successfully typed samples (44.3%, 95% CI 40.9–47.7), significantly higher in Gondar Zuria (51.5%, 95% CI 46.9–56.0) than Tach Armachiho (35.4%, 95% CI 30.5–40.3; p < 0.001), and was found in all but one Kebele.
  • HRP2-based RDT negativity occurred in 39.3% (317/807) of microscopy-confirmed infections, higher in Gondar Zuria (48.7%) than Tach Armachiho (27.6%; p < 0.001); R622I and RDT negativity co-occurred in 22.0% overall (28.9% vs. 12.9%; p = 0.001), and RDT negativity was more common among R622I mutants than wild-type parasites (48.3% vs. 30.7%; p < 0.05).
  • Two k13 C580Y cases were detected in Gondar Zuria (reported as 0.4% in the abstract and section 2.3, but 0.2% in section 2.2), representing the first report in Ethiopia/Horn of Africa; long-read WGS showed a flanking haplotype distinct from Southeast Asian lineages, suggesting local de novo emergence, and both infections were HRP2-RDT negative with no reads mapping to hrp2 or hrp3.
  • R622I persisted year-round, peaking at 60.5% in March overall, and mutants showed higher identity-by-descent than wild-type parasites in Gondar Zuria (0.369 vs. 0.234; p = 3.29e-8) and Tach Armachiho (0.249 vs. 0.172; p = 3.55e-3); RDT-negative R622I infections had higher IBD than RDT-positive R622I infections (0.365 vs. 0.284; p < 0.001).

Methods

  • Health-facility-based cross-sectional genomic surveillance from November 1, 2022 to October 31, 2023 in Gondar Zuria and Tach Armachiho districts, Amhara region, northwest Ethiopia; 903 microscopy-confirmed P. falciparum infections were enrolled (500 from Gondar Zuria, 403 from Tach Armachiho), with mean age 22.1 ± 13.0 years and 59.4% male.
  • Dried blood spots were used for DNA extraction; molecular inversion probe (MIP) panels targeted major drug resistance genes (k13, mdr1, crt, dhfr, dhps) and genome-wide informative SNPs (2,128 MIPs), sequenced on Illumina NextSeq 550; analyses included drug resistance prevalence, linkage disequilibrium, complexity of infection, identity-by-descent, and relatedness networks.
  • Long-read Oxford Nanopore Technology whole-genome sequencing after selective whole-genome amplification was performed on two k13 C580Y samples; flanking haplotypes were compared with 41 publicly available Southeast Asian C580Y parasites, and rainfall data were obtained from CHIRPS.

Limitations

  • The paper states that a major limitation is the use of RDT negativity as a clinical surrogate for pfhrp2/3 gene deletions in microscopy-confirmed cases, without molecular typing of pfhrp2/3, so individual deletion status is not resolved; it also states that data from a single year limit assessment of temporal trends in seasonality.
  • Evident from the text: RDT results were missing for 96/903 participants (10.6%), so RDT analyses use 807 participants; C580Y frequency is reported inconsistently (0.2% in section 2.2 vs. 0.4% in the abstract and section 2.3); and the health-facility-based sampling may not fully represent community transmission.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1013771

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 Prevalence of k13 R622I mutation and RDT negativity in P. falciparum infections in Northwest Ethiopia. (A) Map of study districts and Keabeles (kebele - red dots) where participants were sampled. Administrative boundary data were obtained from the Global Administrative Areas database (GADM, version 4.1, www.gadm.org). (B) Grouped bar plot showing k13 R622I prevalence and HRP2-based RDT negativity and their co-occurrence rates by district (all enrolled participants had microscopically confirmed P. falciparum infection). (C) Stacked bar charts showing the distribution of R622I mutation by RDT result by Kebele. (D) Prevalence of HRP2-based RDT negativity by k13 R622I status and district showing significantly higher RDT negativity in mutant infections compared to wildtype infections in Gondar Zuria (Student’s t-test p = 0.0022). No significant difference in RDT negativity percentage was found in Tach Armachiho. Boxplot center lines show the median value, with upper and lower bounds representing the 25th and 75th quartiles, and whiskers extending to 1.5 × IQR from the lower and upper quartiles. Asterisks (*) denote level of statistically significant differences based on Student’s t-test: p < 0.01 (**), and p ≥ 0.05 (ns, not significant).
Fig 1 Prevalence of k13 R622I mutation and RDT negativity in P. falciparum infections in Northwest Ethiopia. (A) Map of study districts and Keabeles (kebele - red dots) where participants were sampled. Administrative boundary data were obtained from the Global Administrative Areas database (GADM, version 4.1, www.gadm.org). (B) Grouped bar plot showing k13 R622I prevalence and HRP2-based RDT negativity and their co-occurrence rates by district (all enrolled participants had microscopically confirmed P. falciparum infection). (C) Stacked bar charts showing the distribution of R622I mutation by RDT result by Kebele. (D) Prevalence of HRP2-based RDT negativity by k13 R622I status and district showing significantly higher RDT negativity in mutant infections compared to wildtype infections in Gondar Zuria (Student’s t-test p = 0.0022). No significant difference in RDT negativity percentage was found in Tach Armachiho. Boxplot center lines show the median value, with upper and lower bounds representing the 25th and 75th quartiles, and whiskers extending to 1.5 × IQR from the lower and upper quartiles. Asterisks (*) denote level of statistically significant differences based on Student’s t-test: p < 0.01 (**), and p ≥ 0.05 (ns, not significant).CC0 · PubMed Central
Fig 2 Flanking haplotype comparison of the k13 locus in Ethiopian C580Y WGS sample compared to SEA k13 C580Y mutants from Pf7 public database. Dark blue = alternate allele, light blue = reference allele (relative to 3D7) and intermediate blue = mixed genotype.
Fig 2 Flanking haplotype comparison of the k13 locus in Ethiopian C580Y WGS sample compared to SEA k13 C580Y mutants from Pf7 public database. Dark blue = alternate allele, light blue = reference allele (relative to 3D7) and intermediate blue = mixed genotype.CC0 · PubMed Central
Fig 3 Prevalence of the k13 R622I mutation and other partner drug-resistance mutations in monoclonal P. falciparum infections. (A) Combinations of k13 R622I and mdr1 drug resistance mutations implicated in lumefantrine susceptibility, including the mdr1 NFD haplotype (N86 wild type, 184F mutant, and D1246 wild type). (B) Combinations of k13 R622I and crt drug resistance mutations implicated in aminoquinoline susceptibility, including crt (326S, N75E, and K76T). Only monoclonal samples (n = 680) with genotypes for all loci were included. The “intersection size” on the vertical axis on both panels represents the number of isolates.
Fig 3 Prevalence of the k13 R622I mutation and other partner drug-resistance mutations in monoclonal P. falciparum infections. (A) Combinations of k13 R622I and mdr1 drug resistance mutations implicated in lumefantrine susceptibility, including the mdr1 NFD haplotype (N86 wild type, 184F mutant, and D1246 wild type). (B) Combinations of k13 R622I and crt drug resistance mutations implicated in aminoquinoline susceptibility, including crt (326S, N75E, and K76T). Only monoclonal samples (n = 680) with genotypes for all loci were included. The “intersection size” on the vertical axis on both panels represents the number of isolates.CC0 · PubMed Central
Fig 4 k13 mutant and wildtype parasite relatedness. (A) Pairwise IBD sharing between k13 R622I mutant and wild-type P. falciparum parasites within Kebeles across different study districts. Asterisks (*) denote level of statistically significant differences based on Student’s t-test: p< < 0.01 (**), and p< < 0.001 (***). Boxes indicate the interquartile range; the line indicates the median, the whiskers show the 95% confidence intervals and dots show within-Kebele IBD values within each district. (B) Network analysis of highly related parasite pairs (IBD≥ ≥ 0.95) by RDT test results shaped by k13 mutation status. (C) Network analysis of highly related parasite pairs (IBD≥ ≥ 0.95) by district shaped by k13 mutation status. (D) Network analysis of highly related parasites (IBD≥ ≥ 0.95) at Kebele (village) level shaped by k13 mutation status. Each node identifies a unique isolate, and an edge is drawn between two isolates if they meet the IBD threshold. Within panels B, C, and D; the k13 C580Y parasites, shaped as rectangles and encircled by red circles are clustered by RDT results, study district and Kebele level, indicating their clonality. Color codes correspond to RDT results, districts and Kebeles.
Fig 4 k13 mutant and wildtype parasite relatedness. (A) Pairwise IBD sharing between k13 R622I mutant and wild-type P. falciparum parasites within Kebeles across different study districts. Asterisks (*) denote level of statistically significant differences based on Student’s t-test: p< < 0.01 (**), and p< < 0.001 (***). Boxes indicate the interquartile range; the line indicates the median, the whiskers show the 95% confidence intervals and dots show within-Kebele IBD values within each district. (B) Network analysis of highly related parasite pairs (IBD≥ ≥ 0.95) by RDT test results shaped by k13 mutation status. (C) Network analysis of highly related parasite pairs (IBD≥ ≥ 0.95) by district shaped by k13 mutation status. (D) Network analysis of highly related parasites (IBD≥ ≥ 0.95) at Kebele (village) level shaped by k13 mutation status. Each node identifies a unique isolate, and an edge is drawn between two isolates if they meet the IBD threshold. Within panels B, C, and D; the k13 C580Y parasites, shaped as rectangles and encircled by red circles are clustered by RDT results, study district and Kebele level, indicating their clonality. Color codes correspond to RDT results, districts and Kebeles.CC0 · PubMed Central
Fig 5 Monthly prevalence of the k13 R622I mutation, RDT negativity, P. falciparum positivity, and genetic relatedness in parasite samples collected between November 2022 to October 2023 in Gondar Zuria and Tach Armachiho districts, Northwest Ethiopia. (A) Monthly prevalence of k13 R622I mutation and the rate of RDT negativity among P. falciparum isolates, along with rainfall and P. falciparum case count patterns across months per district. (B) Network analysis of highly related monoclonal parasite pairs (IBD ≥ 0.95) by month, where each node represents a unique isolate, and edges are drawn between isolates meeting the IBD threshold; isolates without such connections are not shown, and color codes correspond to different months. Within this panel, C580Y parasites, which are depicted as rectangles and encircled in red, share IBD ≥ 0.95 indicating their clonality and persistence between consecutive months. (C) Monthly means pairwise IBD of P. falciparum isolates by k13 genotype status. Error bars represent the 95% confidence intervals. (D) Distribution of R622I mutation by RDT result status across months of the study districts.
Fig 5 Monthly prevalence of the k13 R622I mutation, RDT negativity, P. falciparum positivity, and genetic relatedness in parasite samples collected between November 2022 to October 2023 in Gondar Zuria and Tach Armachiho districts, Northwest Ethiopia. (A) Monthly prevalence of k13 R622I mutation and the rate of RDT negativity among P. falciparum isolates, along with rainfall and P. falciparum case count patterns across months per district. (B) Network analysis of highly related monoclonal parasite pairs (IBD ≥ 0.95) by month, where each node represents a unique isolate, and edges are drawn between isolates meeting the IBD threshold; isolates without such connections are not shown, and color codes correspond to different months. Within this panel, C580Y parasites, which are depicted as rectangles and encircled in red, share IBD ≥ 0.95 indicating their clonality and persistence between consecutive months. (C) Monthly means pairwise IBD of P. falciparum isolates by k13 genotype status. Error bars represent the 95% confidence intervals. (D) Distribution of R622I mutation by RDT result status across months of the study districts.CC0 · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 20 Not checked · 79 Own results and interpretations

59 more claims

Create a free account to see all 99 claims and to verify the 30 references still open.

See all claims — free account
  • It may state two separate claims as one. 29
  • Probably not a substantial claim. 12

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 80 references

Cited by

See all 12

Metadata

Authors
Zeleke, A. J., Fola, A. A., Tollefson, G. A., Niaré, K., Leonetti, A., Taropawala, O., Marglous, J., Crudale, R., Brhane, B. G., Assefa, A., Kiyuka, P., Parr, J. B., Hailu, A., Tegegne, M. A., & Bailey, J. A.
Affiliations
  • University of Gondar (ET)
  • Brown University (US)
  • Ethiopian Public Health Institute (ET)
  • University of North Carolina at Chapel Hill (US)
  • Kenya Medical Research Institute (KE)
  • Addis Ababa University (ET)
Corresponding author
Zeleke, Ayalew Jejaw
Venue
PLOS Pathogens
Published
2025-12-11
Volume
21
Issue
12
Pages
e1013771
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W4417251261
Cited by
12
References
76
Citations by year
2026: 12
FWCI
6.93
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, public-domain)
  • medRxiv (submittedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc)
  • PubMed (submittedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, public-domain)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • UNC Libraries
Funders
  • European Union (CSA 2020NOE-3102)
  • NIH (R01AI177791)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
Keywords
Plasmodium falciparum, artemisinin resistance, antimalarial drug resistance, long-read whole-genome sequencing, northern Ethiopia, Horn of Africa, molecular surveillance
MeSH terms
Adolescent, Adult, Antigens, Protozoan, Antimalarials, Child, Child, Preschool, Diagnostic Tests, Routine, Drug Resistance, Ethiopia, Female, Humans, Infant, Male, Mutation, Plasmodium falciparum, Protozoan Proteins, Prevalence, Malaria, Falciparum, Polymorphism, Single Nucleotide, Artemisinins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia. https://app.cochat.ai/papers/10.1371/journal.ppat.1013771
The paper
Zeleke, A. J., Fola, A. A., Tollefson, G. A., Niaré, K., Leonetti, A., Taropawala, O., Marglous, J., Crudale, R., Brhane, B. G., Assefa, A., Kiyuka, P., Parr, J. B., Hailu, A., Tegegne, M. A., & Bailey, J. A. (2025). High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013771

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.